These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 20850535)
21. Trypanosoma cruzi: Tc52 released protein-induced increased expression of nitric oxide synthase and nitric oxide production by macrophages. Fernandez-Gomez R; Esteban S; Gomez-Corvera R; Zoulika K; Ouaissi A J Immunol; 1998 Apr; 160(7):3471-9. PubMed ID: 9531308 [TBL] [Abstract][Full Text] [Related]
22. Regulation of Th2 responses and allergic inflammation through bystander activation of CD8+ T lymphocytes in early life. Dubois A; Deruytter N; Adams B; Kanda A; Delbauve S; Fleury S; Torres D; François A; Pétein M; Goldman M; Dombrowicz D; Flamand V J Immunol; 2010 Jul; 185(2):884-91. PubMed ID: 20562264 [TBL] [Abstract][Full Text] [Related]
23. Trypanosoma cruzi: protective response of vaccinated mice is mediated by CD8+ cells, prevents signs of polyclonal T lymphocyte activation, and allows restoration of a resting immune state after challenge. Paiva CN; Castelo-Branco MT; Lannes-Vieira J; Gattass CR Exp Parasitol; 1999 Jan; 91(1):7-19. PubMed ID: 9920038 [TBL] [Abstract][Full Text] [Related]
24. Dendritic cell (DC)-based anti-infective strategies: DCs engineered to secrete IL-12 are a potent vaccine in a murine model of an intracellular infection. Ahuja SS; Reddick RL; Sato N; Montalbo E; Kostecki V; Zhao W; Dolan MJ; Melby PC; Ahuja SK J Immunol; 1999 Oct; 163(7):3890-7. PubMed ID: 10490989 [TBL] [Abstract][Full Text] [Related]
25. Vaccination of dendritic cells loaded with interleukin-12-secreting cancer cells augments in vivo antitumor immunity: characteristics of syngeneic and allogeneic antigen-presenting cell cancer hybrid cells. Suzuki T; Fukuhara T; Tanaka M; Nakamura A; Akiyama K; Sakakibara T; Koinuma D; Kikuchi T; Tazawa R; Maemondo M; Hagiwara K; Saijo Y; Nukiwa T Clin Cancer Res; 2005 Jan; 11(1):58-66. PubMed ID: 15671528 [TBL] [Abstract][Full Text] [Related]
26. T-bet-independent effects of IL-12 family cytokines on regulation of Th17 responses to experimental T. cruzi infection. Cobb D; Hambright D; Smeltz RB J Leukoc Biol; 2010 Nov; 88(5):965-71. PubMed ID: 20807701 [TBL] [Abstract][Full Text] [Related]
27. Dendritic cells pulsed with an anti-idiotype antibody mimicking carcinoembryonic antigen (CEA) can reverse immunological tolerance to CEA and induce antitumor immunity in CEA transgenic mice. Saha A; Chatterjee SK; Foon KA; Primus FJ; Sreedharan S; Mohanty K; Bhattacharya-Chatterjee M Cancer Res; 2004 Jul; 64(14):4995-5003. PubMed ID: 15256474 [TBL] [Abstract][Full Text] [Related]
28. Trypanosoma cruzi Infection Imparts a Regulatory Program in Dendritic Cells and T Cells via Galectin-1-Dependent Mechanisms. Poncini CV; Ilarregui JM; Batalla EI; Engels S; Cerliani JP; Cucher MA; van Kooyk Y; González-Cappa SM; Rabinovich GA J Immunol; 2015 Oct; 195(7):3311-24. PubMed ID: 26324777 [TBL] [Abstract][Full Text] [Related]
29. The Trypanosoma cruzi Tc52-released protein induces human dendritic cell maturation, signals via Toll-like receptor 2, and confers protection against lethal infection. Ouaissi A; Guilvard E; Delneste Y; Caron G; Magistrelli G; Herbault N; Thieblemont N; Jeannin P J Immunol; 2002 Jun; 168(12):6366-74. PubMed ID: 12055254 [TBL] [Abstract][Full Text] [Related]
30. Regulation of proinflammatory Th17 responses during Trypanosoma cruzi infection by IL-12 family cytokines. Cobb D; Smeltz RB J Immunol; 2012 Apr; 188(8):3766-73. PubMed ID: 22412196 [TBL] [Abstract][Full Text] [Related]
31. Involvement of CD4(+) Th1 cells in systemic immunity protective against primary and secondary challenges with Trypanosoma cruzi. Hoft DF; Schnapp AR; Eickhoff CS; Roodman ST Infect Immun; 2000 Jan; 68(1):197-204. PubMed ID: 10603388 [TBL] [Abstract][Full Text] [Related]
32. Trypanosoma cruzi: analysis of cellular and humoral response against a protective recombinant antigen during experimental Chagas' disease. Taibi A; Espinoza AG; Ouaissi A Immunol Lett; 1995 Dec; 48(3):193-200. PubMed ID: 8867851 [TBL] [Abstract][Full Text] [Related]
33. Type 1 immunity provides optimal protection against both mucosal and systemic Trypanosoma cruzi challenges. Hoft DF; Eickhoff CS Infect Immun; 2002 Dec; 70(12):6715-25. PubMed ID: 12438346 [TBL] [Abstract][Full Text] [Related]
34. Interferon- or interleukin-10 production is induced by related Trypanosoma cruzi antigens. Cuna WR; Encina JL; Cuna CR J Parasitol; 2000 Apr; 86(2):295-9. PubMed ID: 10780548 [TBL] [Abstract][Full Text] [Related]
35. Dendritic cell (DC)-based protection against an intracellular pathogen is dependent upon DC-derived IL-12 and can be induced by molecularly defined antigens. Berberich C; Ramírez-Pineda JR; Hambrecht C; Alber G; Skeiky YA; Moll H J Immunol; 2003 Mar; 170(6):3171-9. PubMed ID: 12626575 [TBL] [Abstract][Full Text] [Related]
36. Natural killer T cells are critical for dendritic cells to induce immunity in Chlamydial pneumonia. Joyee AG; Qiu H; Fan Y; Wang S; Yang X Am J Respir Crit Care Med; 2008 Oct; 178(7):745-56. PubMed ID: 18596223 [TBL] [Abstract][Full Text] [Related]
37. IL-10-IFN-γ double producers CD4+ T cells are induced by immunization with an amastigote stage specific derived recombinant protein of Trypanosoma cruzi. Flores-García Y; Rosales-Encina JL; Satoskar AR; Talamás-Rohana P Int J Biol Sci; 2011; 7(8):1093-100. PubMed ID: 21927578 [TBL] [Abstract][Full Text] [Related]